iSpecimen Inc.
ISPC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.00 | 0.07 | 0.09 |
| FCF Yield | -438.70% | -233.19% | -74.18% | -18.34% |
| EV / EBITDA | -0.03 | -0.27 | 0.34 | -6.75 |
| Quality | ||||
| ROIC | -351.30% | -112.40% | -49.70% | -17.84% |
| Gross Margin | 42.93% | 51.45% | 54.27% | 52.86% |
| Cash Conversion Ratio | 0.66 | 0.52 | 0.57 | 1.19 |
| Growth | ||||
| Revenue 3-Year CAGR | -3.70% | -3.75% | 8.32% | 37.34% |
| Free Cash Flow Growth | 21.39% | -17.13% | 23.04% | -741.58% |
| Safety | ||||
| Net Debt / EBITDA | 0.12 | 0.24 | 1.72 | 4.15 |
| Interest Coverage | -57.84 | -48.40 | -42.63 | -2.82 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -232.18 | -189.12 | -50.94 | 102.13 |